Abstract
In the motor synapses of the mouse diaphragm, we recorded the miniature endplate potentials (MEPPs) and multiquantal endplate potentials induced by stimulation of the phrenic nerve (EPPs). Prolonged continuous rhythmic stimulation (50 Hz for 40 seconds) caused a depression of the synaptic transmission in the form of a gradual biphasic decrease in the quantal content of EPPs in the train. A rapid decrease in the quantal content of the EPPs to 50% of the amplitude of the first EPPs in the train (EPP1) during the first 10 seconds of activity was followed by a slower decrease in the EPP quantum content to 35–40% of EPP1 by the 40th second of stimulation. Blockage of the α7 nicotinic acetylcholine receptors by methyllycaconitine (20 nM), as well as ryanodine receptors by ryanodine (3 µM), or small-conductance calcium-activated potassium channels of the SK-type by apamin (1 µM) significantly reduced the development of depression; the EPP quantal content decreased to 65–70% of EPP1 by the 10th second of stimulation and maintained at this level for the next 30 seconds of stimulation. It was concluded that in mouse cholinergic motor synapses, the mechanism of transient depression of transmission may be autoinhibition of acetylcholine quantal secretion by endogenous acetylcholine/choline, which activates the α7 nicotinic acetylcholine receptors and triggers the signaling cascade that involves presynaptic ryanodine receptors and SK channels.
Similar content being viewed by others
References
Kabbani, N. and Nichols, R.A., Trends Pharmacol. Sci., 2018, vol. 39, pp. 354–366.
Alkondon, M., Pereira, E.F., Cortes, W.S., Maelicke, A., and Albuquerque, E.X., Eur. J. Neurosci., 1997, vol. 9, pp. 2734–2742.
Papke, R.L. and Porter, PapkeJ.K., Br. J. Pharmacol, 2002, vol. 137, pp. 49–61.
Uteshev, V.V., Meyer, E.M., and Papke, R.L., J. Neurophysiol., 2003, vol. 89, pp. 1797–1806.
Shen, J. and Yakel, J.L., Acta Pharmacol. Sin, 2009, vol. 30, pp. 673–680.
Uteshev V. V., in: Advances in Experimental Medicine and Biology, 2012, pp. 603–638.
Papke, R.L., Biochem. Pharmacol., 2014, vol. 89, pp. 1–11.
Dani, J.A. and Bertrand, D., Annu. Rev. Pharmacol. Toxicol., 2007, vol. 47, pp. 699–729.
Koukouli, F. and Maskos, U., Biochem. Pharmacol., 2015, vol. 97, pp. 378–387.
Gaydukov, A.E., Bogacheva, P.O., Tarasova, E.O., and Balezina, O.P., Acta Naturae, 2014, vol. 6, pp. 110–115.
Gaydukov, A.E. and Balezina, O.P., Acta Naturae, vol. 9, pp. 110–113.
Tarasova, E.O., Miteva, A.S., Gaidukov, A.E., and Balezina, O.P., Biochem. Suppl. Ser. A Membr. Cell Biol., 2015, vol. 9, pp. 318–328.
McLachlan, E.M. and Martin, A.R., J. Physiol., 1981, vol. 311, pp. 307–324.
Gerasimova, E., Lebedeva, J., Yakovlev, A., Zefirov, A., Giniatullin, R., and Sitdikova, G., Neuroscience, 2015, vol. 303, pp. 577–585.
Regehr, W.G., Cold Spring Harb. Perspect. Biol., 2012, vol. 4.
Fioravante, D. and Regehr, W.G., Curr. Opin. Neurobiol., 2011, vol. 21, pp. 269–274.
Ruiz, R., Cano, R., Casanas, J.J., Gaffield, M.A., Betz, W.J., and Tabares, L., J. Neurosci., 2011, vol. 31, pp. 2000–2008.
Cano, R., Ruiz, R., Shen, C., Tabares, L., and Betz, W.J., Cell Calcium, 2012, vol. 52, pp. 321–326.
Hosoi, N., Holt, M., and Sakaba, T., Neuron, 2009, vol. 63, pp. 216–229.
Neher, E., Front. Synaptic Neurosci., 2010, vol. 2, p. 144.
Forsythe, I.D., Tsujimoto, T., Barnes-Davies, M., Cuttle, M.F., and Takahashi, T., Neuron, 1998, vol. 20, pp. 797–807.
Neher, E. and Sakaba, T., Neuron, 2008, vol. 59, pp. 861–872.
Mochida, S., Few, A.P., Scheuer, T., and Catterall, W.A., Neuron, 2008, vol. 57, pp. 210–216.
Catterall, W.A. and Few, A.P., Neuron, 2008, vol. 59, pp. 882–901.
Nanou, E., Yan, J., Whitehead, N.P., Kim, M.J., Froehner, S.C., Scheuer, T., and Catterall, W.A., Proc. Natl. Acad. Sci. U.S.A., 2016, vol. 113, pp. 1068–1073.
Mochida, S., Proc. Japan Acad. Ser. B, vol. 93, pp. 802–820.
Castillo, P.E., Cold Spring Harb. Perspect. Biol, 2012, vol. 4, p. a005728.
Atwood, B.K., Lovinger, D.M., and Mathur, B.N., Trends Neurosci., 2014, vol. 37, pp. 663–673.
Tomàs, J., Santafè, M.M., Garcia, N., Lanuza, M.A., Tomàs, M., Besalduch, N., Obis, T., Priego, M., and Hurtado, E., J. Neurosci. Res., 2014, vol. 92, pp. 543–554.
Prior, C. and Singh, S., Br. J. Pharmacol., 2000, vol. 129, pp. 1067–1074.
Oliveira, L. Timoteo, M.A., and Correia-de-Sá, P., Eur. J. Neurosci., 2002, vol. 15, pp. 1728–1736.
Khaziev, E., Samigullin, D., Zhilyakov, N., Fatikhov, N., Bukharaeva, E., Verkhratsky, A., and Nikolsky, E., Front. Physiol., 2016, vol. 7, p. 621.
Parikh, V. and Sarter, M., J. Neurochem., 2006, vol. 97, pp. 488–503.
Gusev, A.G. and Uteshev, V.V., J. Pharmacol. Exp. Ther., 2010, vol. 332, pp. 588–598.
Corradi, J. and Bouzat, C., Mol. Pharmacol., 2016, vol. 90, pp. 288–299.
Sharma, G. and Vijayaraghavan, S., Neuron, 2003, vol. 38, pp. 929–939.
Griguoli, M., Scuri, R., Ragozzino, D., and Cherubini, E., Eur. J. Neurosci., 2009, vol. 30, pp. 1011–1022.
Davis, G.W. and Müller, M., Annu. Rev. Physiol., 2015, vol. 77, pp. 251–270.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gaydukov, A.E., Bogacheva, P.O. & Balezina, O.P. The Participation of Presynaptic Alpha7 Nicotinic Acetylcholine Receptors in the Inhibition of Acetylcholine Release during Long-Term Activity of Mouse Motor Synapses. Neurochem. J. 13, 20–27 (2019). https://doi.org/10.1134/S1819712419010082
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712419010082